menu
Nerve Stimulators Market is estimated to be US$ 8.2 billion by 2030 with a CAGR of 8.90% during the forecast period
Nerve Stimulators Market is estimated to be US$ 8.2 billion by 2030 with a CAGR of 8.90% during the forecast period
The Global Nerve Stimulators Market accounted for US$ 3.5 billion in 2020 and is estimated to be US$ 8.2 billion by 2030 and is anticipated to register a CAGR of 8.90%. Neurostimulation usually refers to the electromagnetic approaches to neuromodulator.

Nerve Stimulators Market

The Global Nerve Stimulators Market accounted for US$ 3.5 billion in 2020 and is estimated to be US$ 8.2 billion by 2030 and is anticipated to register a CAGR of 8.90%. Neurostimulation usually refers to the electromagnetic approaches to neuromodulator. Neurostimulation technology can improve the life quality of these who are severely paralyzed or affected by profound losses to varied sense organs, also as for permanent reduction of severe, chronic pain which might otherwise require constant (around-the-clock), high-dose opioid therapy (such as neuropathic pain and spinal-cord injury). It is the key a part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. Within the case of neural stimulation, mostly an electrical stimulation is employed and charge-balanced biphasic constant current waveforms or capacitive coupled charge injection approaches are adopted. Alternatively, transracial magnetic stimulation and transracial electric stimulation are proposed as non-invasive methods during which either a magnetic flux or transracially applied electric currents cause neurostimulation.

The report “Global Nerve Stimulators  Market, By Type (Spinal Cord Stimulator (SCS), Deep Brain Stimulator (DBS) and Vagus Nerve Stimulator (VNS)), By Application (Parkinson’s Disease, Chronic Pain, Epilepsy and Depression), By End-User (Trauma Centers, Ambulatory Surgical Centers and Hospital & Clinics) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” 

Key Highlights:

·         In 2021, NeuraLace Medical, Inc., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced that it has received FDA 510(k) clearance for Axon Therapy to non-invasively stimulate peripheral nerves and provide chronic nerve pain relief.

 

Analyst View:

There is some evidence that peripheral nerve stimulation helps certain types of chronic pain, such as peripheral nerve pain and pain after surgery. Initial pain relief is often followed by a gradual decline in effectiveness. The growth of this market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulator, and awareness on neurodegenerative disorders.

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Nerve-Stimulators-Market-By-1423

Key Market Insights from the report:

The Global Nerve Stimulators Market accounted for US$ 3.5 billion in 2020 and is estimated to be US$ 8.2 billion by 2030 and is anticipated to register a CAGR of 8.90%. The Global Nerve Stimulators Market report segments the market on the basis of product type, application, end-user and region.

·         Based on Product type, the Global Nerve Stimulators Market is segmented into the Spinal Cord Stimulator (SCS), Deep Brain Stimulator (DBS) and Vagus Nerve Stimulator (VNS).

·         Based on Application, the Global Nerve Stimulators Market is segmented into Parkinson’s disease, Chronic Pain, Epilepsy and Depression.

·         Based on End-User, the Global Nerve Stimulators Market is segmented into Trauma Centers, Ambulatory Surgical Centers and Hospital & Clinics.

·         By region, the Global Nerve Stimulators Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is accounted for largest market share in terms of revenue contribution and is expected to maintain its dominance over the forecast period. 

Competitive Landscape:

The Key players operating in the global Nerve Stimulators market are NeuroPace, Inc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, Cochlear Ltd., Cyberonics, Inc., Medtronic plc and St Jude Medical, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.